Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > XCUR Exicure > Detailed Quotes

XCUR Exicure

Watchlist
2.070
-0.090-4.17%
Close 07/01 16:00 ET
2.060
-0.01-0.48%
Post Mkt Price 07/01 18:58 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
2.210
Open
2.100
Turnover
480.23K
Low
2.000
Pre Close
2.160
Volume
231.71K
Market Cap
8.47M
P/E(TTM)
Loss
52wk High
59.400
Shares
4.09M
P/E(Static)
Loss
52wk Low
2.000
Float Cap
6.56M
Bid/Ask %
60.00%
Historical High
115.200
Shs Float
3.17M
Volume Ratio
0.02
Historical Low
2.000
Dividend TTM
--
Div Yield TTM
--
P/B
2.65
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
7.31%
Amplitude
9.72%
Avg Price
2.072
Lot Size
1
Float Cap
6.56M
Bid/Ask %
60.00%
Historical High
115.200
Shs Float
3.17M
Volume Ratio
0.02
Historical Low
2.000
Dividend TTM
--
P/B
2.65
Dividend LFY
--
Turnover Ratio
7.31%
Amplitude
9.72%
Avg Price
2.072
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington’s disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
CEO: Schroff Ph.D., Matthias G.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top